Immunoexpression of Claudin 4 in Gastric Adenocarcinomas.

Curr Health Sci J · 2022 · PMC10248485 · PMID 37304806

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

at the limit of significancep=0.053so close (0.05 < p ≤ 0.1)

The statistical analysis of Claudin 4 immunoexpression indicated values at the limit of significance in relation to the tumor grade (p=0.053, χ2 test), without associations with the histopathological type (p=0.291, χ2 test), and tumor stage (p=0.183, χ2 test).

also in 88 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.